Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Press Release

Oxfam Reaction to Announced US Support of WTO Trips Waiver on COVID Vaccines

WASHINGTON -

In response to today’s announcement that the US Trade Representative is supporting waiving intellectual property rights on COVID-19 vaccines, Abby Maxman, Oxfam America’s President and CEO, made the following statement:

"President Biden and US Trade Representative Katherine Tai have recognized that Pharma’s ‘business as usual’ is killing us. In this moment of crisis, we applaud their willingness to pursue a new path that prioritizes public health over private profits.

"Today, we celebrate the momentous decision by President Biden and his administration to engage with the rest of the world to pull down all barriers standing in the way of everyone everywhere getting access to COVID vaccines.

"This is a testament to the widespread public movement calling for an end to vaccine monopolies. It is also a testament to an administration that listens and is willing to do whatever it takes to defeat COVID-19.

"Over the past year, nurses, doctors, Nobel Laureates, former heads of state, artists, economists, public health activists and more than two million people from around the world have rallied together to call on President Biden to reassert the US’s moral and public leadership on the world stage.  Today President Biden answered that call.

"We are at a crucial inflexion point in the fight against the coronavirus, yet we have remained essentially at the mercy of a handful of giant pharmaceutical corporations that have monopoly control over the life-saving technologies we all need. This may now begin to change.

"Loosening the monopoly grip that pharmaceutical companies have on these life-saving vaccines is an essential step toward increased manufacturing that would lead to worldwide immunization, helping the US and everyone else. We will now look to the White House for leadership in a strong WTO outcome, in urgently insisting on the transfer of technologies through the World Health Organization Covid-19 Technology Access pool, and in investing strategically to build up regional vaccine hubs to defeat this and future pandemics.

"The horrific situation in India is a warning to all of us that if we don’t move urgently to share the vaccine technology and scale up manufacturing so everyone, everywhere can have access to these lifesaving vaccines, we will never get the upper hand on COVID anywhere.”

###

Oxfam America logo

Oxfam is a global organization working to end the injustice of poverty. We help people build better futures for themselves, hold the powerful accountable, and save lives in disasters.

'Bolsonaro Out!': Massive Protests as Brazil's Covid-19 Death Toll Tops 500,000

"We are on the street to defend our country, our people, our lives, our culture, our education, our economy. We can no longer die of Covid."

Brett Wilkins, staff writer ·


Summit Participants Embrace 'Vaccine Internationalism' to End Pandemic

"Our goal is simple: to end the pandemic as quickly as possible by securing Covid-19 vaccines for all," says the coordinator of Progressive International's four-day virtual summit.

Brett Wilkins, staff writer ·


As Iran Elects New President, Experts Urge Biden to Rejoin Nuclear Deal, Lift Sanctions

"The Biden administration must remain resolute and seek a break from the disastrous conditions that helped contribute to this result."

Brett Wilkins, staff writer ·


UN General Assembly Condemns Myanmar Junta Violence, Urges Arms Embargo

Member nations voted 119-1 in favor of the resolution, which also calls for a return to the country's fragile democracy.

Brett Wilkins, staff writer ·


Dems Introduce Abolition Amendment to Scrap Constitution's 'Slavery Clause'

"The loophole in our Constitution's ban on slavery not only allowed slavery to continue, but launched an era of discrimination and mass incarceration that continues to this day," said Sen. Jeff Merkley.

Julia Conley, staff writer ·